Compare DOMO & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOMO | INGN |
|---|---|---|
| Founded | 2010 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.3M | 173.2M |
| IPO Year | 2018 | 2013 |
| Metric | DOMO | INGN |
|---|---|---|
| Price | $4.71 | $6.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $11.15 | $11.00 |
| AVG Volume (30 Days) | ★ 1.6M | 303.1K |
| Earning Date | 06-10-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | N/A | ★ N/A |
| Revenue | $317,044,000.00 | ★ $348,668,000.00 |
| Revenue This Year | $4.66 | $7.92 |
| Revenue Next Year | $7.89 | $7.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $3.45 | $5.34 |
| 52 Week High | $18.49 | $9.13 |
| Indicator | DOMO | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.25 | 47.56 |
| Support Level | $4.51 | $5.67 |
| Resistance Level | $6.62 | $6.19 |
| Average True Range (ATR) | 0.40 | 0.42 |
| MACD | 0.21 | -0.00 |
| Stochastic Oscillator | 64.69 | 45.36 |
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.